Literature DB >> 1381949

Wilms' tumor-specific methylation pattern in 11p13 detected by PFGE.

B Royer-Pokora1, S Schneider.   

Abstract

The analysis of 2,550 kb from 11p13 in Wilms' tumor (WT) material revealed two regions that differed significantly in their methylation between tumor and normal tissue. In WT a hypomethylated area defined by an NruI and MluI recognition site 100-150 kb centromeric of the WT gene WT1 (site A) and hypermethylation defined by an NruI and SacII site 100 kb telomeric of the WT1 gene were found (site B). The degree of methylation in region B varied between 20 and 100% in the different samples; the highest level was observed in tumors without preoperative chemotherapy. The CpG island 5' of the WT1 gene was partially methylated in 2/29 tumors analyzed. The methylation state of regions A and B could reflect the normal pattern present in a subset of embryonal kidney cells, from which WT develops.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1381949     DOI: 10.1002/gcc.2870050207

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  5 in total

1.  Inhibition of tumorigenesis by a cytosine-DNA, methyltransferase, antisense oligodeoxynucleotide.

Authors:  S Ramchandani; A R MacLeod; M Pinard; E von Hofe; M Szyf
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

2.  Correlation of germ-line mutations and two-hit inactivation of the WT1 gene with Wilms tumors of stromal-predominant histology.

Authors:  V Schumacher; S Schneider; A Figge; G Wildhardt; D Harms; D Schmidt; A Weirich; R Ludwig; B Royer-Pokora
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-15       Impact factor: 11.205

3.  Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations.

Authors:  S Schneider; G Wildhardt; R Ludwig; B Royer-Pokora
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

4.  Maintaining the unmethylated state.

Authors:  Steven S Smith
Journal:  Clin Epigenetics       Date:  2013-09-30       Impact factor: 6.551

5.  Chemotherapy and terminal skeletal muscle differentiation in WT1-mutant Wilms tumors.

Authors:  Brigitte Royer-Pokora; Manfred Beier; Artur Brandt; Constanze Duhme; Maike Busch; Carmen de Torres; Hans-Dieter Royer; Jaume Mora
Journal:  Cancer Med       Date:  2018-03-15       Impact factor: 4.452

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.